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Acute proliferative glomerulonephritis (AGN) after streptococcal infections is
thought to be an autoimmune disease. Although it is known that the disease is trig-
gered by infections with so-called nephritogenic strains ofStreptococcus pyogenes, the
pathogenesis hasbeen poorly understood mainly because the antigens involved have
not been identified.
Recentlyithasbecomeincreasingly clearthat the Mproteinmoleculesprotruding
from the surface of group A streptococci contain epitopes capable of eliciting au-
toimmune reactions with specific host tissues. Shared sequences oftypes 5, 6, and
19 Mproteins have been shown to evoke antibodies that react with several myocar-
dial and skeletal muscle proteins, including myosin, tropomyosin, and other as yet
unidentified proteins (1-6). Most recently, Goroncy-Bermes et al. (7) showed that
an mAb raised against human renal cortex crossreactedwith types 6 and 12 Mpro-
teins, providing evidence that Mproteins ofnephritogenic strains share antigenic
determinants with renal glomeruli. These observed crossreactivities havehampered
the development ofavaccine against streptococcal infections because ofthe fear that
autoimmune epitopes in the Mprotein molecule may cause rather than prevent the
poststreptococcal infectious sequelae, acute rheumatic fever, and acute glomerulo-
nephritis.
The Mprotein molecules radiate as a-helical coiled-coil fibrils from the bacterial
cell surface and this protein is the major virulence determinant ofS. pyogenes bac-
teria (8, 9). The fibrils render the organisms resistant to recognition and ingestion
by phagocytes ofthe nonimmune host (10). The resistance to phagocytosis is over-
come onlyby antibodies directed towards protectiveepitopes on the Mprotein mol-
ecule (8). In our search for protective antibodies against type 1 streptococci, a sero-
type associated with the development of both acute rheumatic fever and acute
proliferative glomerulonephritis (11), we identified protective as well as tissue cross-
reactive epitopes in the NH2-terminal part oftype 1 Mprotein (12). We have shown
that a tetrapeptide sequence oftype 1 M protein specifies a renal glomerular cross-
reactive epitope. Antibodies against this region reacted with renal glomeruli in a
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cellular distribution as demonstrated by immunofluorescence tests of frozen sections
of human renal cortex (12).
Here we report that antibodies directed against a renal glomerular crossreactive
epitope of the NH2-terminal region of type 1 M protein react with mesangial cells
cultured from isolated glomeruli. The intermediate filament protein vimentin, which
shares limited amino acid sequences with type 1 streptococcal M protein, is identified




Purified bovine vimentin (57 kD), purified chicken desmin (53
kD), and a polyclonal antiserum to human vimentin were purchased from ICN Immunobio-
logicals (Lisle, IL). mAbs to human vimentin and human desmin were obtained from
Boehringer Mannheim Biochemicals (Indianapolis, IN) . Antisera against the synthetic pep-
tide SMl(1-19) (23-26)C of type 1 M protein were raised in a previous study (13) in which
the peptide was named SMl(1-20) (24-26)C. We have since renamed the peptide SM1(1-19)
(23-26)C ; because of the Ml sequence, either deletion yields the same peptide sequence and
the tetrapeptide represented by residues 23-26 specifies the renal glomerular crossreactive
epitope (12) . Antiserum 8652, which showed the strongest crossreactivity with human renal
glomeruli, was affinity purified over a column of Afft-Gel 10 (Bio-Rad Laboratories, Rich-
mond, CA) to which the synthetic peptides SMl(1-19) (23-26)C or SM1(23-26)C had been
covalently linked, as described by Kraus and Beachey (12).
Culture ofRat Glomerular Mesangial Cells.
￿
Glomeruli were isolated and cultured mesangial
cells were obtained as described ('-4-16). Briefly, kidneys were removed from ti 100-g female
Wistar rats aseptically and the cortices were incised into small pieces and gently mashed by
the finger tip. The suspension of mashed tissue was passed through stainless sieves at 60,
80, 120, and 280 meshes in succession. The tissue pieces collected on the 280-mesh sieve were
isolated glomeruli that were cultured in Eagle's MEM, supplemented with 20% FCS, with
5° Io C02 in the atmosphere at 37°C . After N4 wk, the outgrown cells from cultured
glomeruli reached confluency and were subcultured using trypsin. Cultured mesangial cells
were obtained and maintained by this procedure. All experiments were performed on cells
within 15 passages.
Extraction ofProteinsfrom Cultured Mesangial Cells.
￿
Mesangial cells were grown to confluency
(N10' cells/dish), rinsed with 0.02 M phosphate, 0.15 M NaCl, pH 7.4 (PBS), and scraped
from the dishes. The cells were then washed twice with PBS and treated with a buffer con-
taining 8 M urea, 100 mM Tris HC1, 2 M NaCl, 1% /3-ME, pH 7.0 . About 5 x 10' cells
were rotated end-over-end in 1 ml buffer for 3 h at RT. Insoluble material was pelleted and
the supernatant was mixed with electrophoresis sample buffer (17), which contained 1% SDS
and was subjected to SDS-PAGE.
ELISA.
￿
ELISAs were performed as previously described (12) using SM1(19-32)C (0.5
lAg/well) as the solid phase antigen. ELISA inhibition tests were performed by incubating
a constant dilution (1 :200) of antiserum 8652 for 30 min at 37°C with serial dilutions of
synthetic peptides before adding to the antigen-coated microtiter wells. The dilution of im-
mune serum used in the inhibition assays gave an absorbance reading at 0.5-0.6 at 450 nm
in the absence of inhibiting antigens.
SDS-PAGE and Western Blots.
￿
SDS-PAGE was performed in 8% polyacrylamide slab gels
according to the method of Laemmli (17) and Western blot analyses were performed as previ-
ously described by Towbin et al. (18). Western blot inhibition tests were performed by pre-
incubating the appropriately diluted antiserum with a 100-JAM concentration of synthetic




Quantitative amino acid analysis was performed on peptide samples
hydrolyzed in constant boiling HCl with an automatic amino acid analyzer (model 121 MB;
Beckman Instruments, Inc., Fullerton, CA) (19). Amino acid sequence analysis was performedKRAUS ET AL.
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with a microsequenator (model 890C ; Beckman Instruments, Inc.) according to the prin-
ciples first described by Edman and Begg (20) and as previously described (19) .
Synthesis ofHuman Vimentin Peptides .
￿
Peptide copies from two regions ofhuman vimentin
(21) containing the tripeptide sequence Arg-Leu-Arg were synthesized by the solid phase
method of Merrifield (22), as described (23) . The synthetic peptides were cleaved, deblocked
with hydrofluoric acid, and purified by gel filtration on a column of Sephadex G10 (Phar-
macia Fine Chemicals, Uppsala, Sweden) as previously described (19) . The purity and com-
position ofthe peptide were assured byHPLC on UltrasphereODS2 (Whatman Inc ., Clifton,
NJ), by quantitative amino acid analysis, and by automatedEdman degradation to the penul-
timate amino acid residue (19) . The peptides were synthesized with a COOH-terminal cys-
teine to enable coupling to a carrier molecule using a bifunctional crosslinking reagent . The
peptide copies ofregions ofhuman vimentin are designated SV(63-73)Cand SV(178-188)C .
The peptides SMl(1-12)C, SMl(1-26)C, SM1(19-32)C, and SMl(23-26)C were synthesized
in a previous study (12) .
Indirect Immunofluorescence Assays.
￿
Rat mesangial cells and rat skin fibroblasts (CRL 1213 ;
American Type Culture Collection, Rockville, MD) were grown for 2 d on cover slips in Eagle's
MEM, supplemented with 20°Io FCS, with 5% C02 in the atmosphere at 37°C . The cells
on the cover slips were rinsed withPBS and then fixed with 1% paraformaldehyde for 5 min .
The cover slips were washed in PBS, incubated with purified crossreactive antibodies at a
dilution of 1:4 in PBS for 30 min at room temperature, washed thoroughly with PBS, and
incubated with fluorescein-conjugated goat anti-rabbit IgG (CooperBiomedical, Inc ., Mal-
vern, PA) at a dilution of 1 :40 inPBS for 30 min at room temperature . After washing again,
the cover slips were mounted in gelvatol on microscope slides and examined with a fluores-
cence microscope (Carl Zeiss, Inc., Thornwood, NY) . Indirect immunofluorescence tests with
frozen sections (4um thick) ofrat and normalhuman renal cortex were performed as previ-
ously described (1, 24) . The specificity of the crossreactive antibodies was tested by im-
munofluorescence inhibition assays . Theimmune serum 8652 was preincubated at a dilution
of 1 :4 in PBS for 30 min at 37°C with synthetic peptides at a concentration of 100 pM or
with 0.5 mg/ml of vimentin or desmin, and then used in the indirect immunofluorescence
tests as described (1, 24) .
Results
Previous studies have shown that antisera raised against synthetic peptides of the
NH 2 terminus of type 1 M protein react with human, mouse, and rat glomeruli
(12) . The crossreactive epitope was localized to a tetrapeptide sequence Ile-Arg-Leu-
Arg at positions 23-26 from the NH2-terminal end of the mature type 1 M protein
molecule (12) . The purpose of the present study was to identify the autoimmune
target in host tissues .
Crossreactivity with Cultured Mesangial Cells and Fibroblasts .
￿
Since the binding pat-
tern of the crossreactive antibodies in the glomeruli suggested mesangial cell distri-
bution of the antigens, we isolated rat glomeruli and used them to obtain primary
cultures of mesangial cells (14) . The cells were cultured on cover slips and used in
indirect immunofluorescence tests . Antibodies from the strongest crossreactive an-
tiserum 8652 (ELISA titer against Ile, Arg, Leu, Arg, 1 :3,200) raised against SM1(1-19)
(23-26)C were affinity purified over a column of Affi-Gel 10 to which the synthetic
peptide had been covalently linked (12) . The purified antibodies(ELISA titer against
Ile, Arg, Leu, Arg, 1:1,600) reacted with the mesangial cells in a reticular pattern
(Fig . 1 A) . The reaction was totally inhibited by preincubation ofthe antibodies with
SMl(1-26)C (Fig . 1 B) . Similar results were obtained with antibodies (ELISA titer
against Ile, Arg, Leu, Arg, 1:800) purified over an Ile-Arg-Leu-Arg-Cys-Affi-Gel
10column (data not shown), suggesting that antibodies directed against the COOH-484
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FIGURE 1 .
￿
Immunoftuorescence staining of mesangial cells (top) and fibroblasts (bottom) by syn-
thetic peptide antiserum . (A and C) The cells were treated with affinity-purified crossreactive
antibodies raised against SMI(1-19)(23-26)C at a dilution of 1 :4 in PBS. (B and D) Preincuba-
tion ofpurified antibodies with the syntheticpeptideSMI(1-26)C totally inhibited the crossreac-
tivity (x 500) .
terminal region of the peptide were responsible for the crossreactions . Incubation
ofthe crossreactive antibodies with rat skin fibroblasts showed a similar fibrillar staining
pattern (Fig. 1 C) ; the reaction was also totally inhibited by preincubation of the
antiserum with SM1(1-26)C (Fig . 1 D) . The patterns of antibody binding in the
two cell types suggested a reaction with a classofprotein fibrilsknown as intermediate
filaments or 10-nm filaments .
Identification of CrossreactioeAntigen .
￿
To identify the crossreactive antigen, cultured
mesangial cellswere extracted with abuffer containing 8Murea, 100mM Tris HCl,
2MNaCl, 0.1% a-ME, pH 7 .0, and the extracted proteins were analyzed by SDS-
PAGE (Fig . 2, lane 1) . Forease of comparison, the two proteins, vimentin anddesmin,
composing the intermediate filaments ofglomerular mesangial cells (25), were pur-
chased commercially (see Materials and Methods) andapplied to thesame8% SDS-
PAGE (Fig . 2, lanes 2 and 3, respectively) . Several protein bands were detected in
the mesangial cell extract (Fig. 2, lane 1) . Three of these reacted with anti-M pro-
tein peptide antibodies purified from rabbit antiserum 8652 ; they migrated as 56-,
52-, and 49-kD polypeptides (Fig . 2, lane 4) . Furthermore, the antibodies reacted
with purified vimentin but not desmin (Fig. 2, lanes 5 and 6) . The reaction withKRAUS ET AL .
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FICURS 2. Identification of crossreactive antigens.
(Lanes 1-3) Coomassie blue-stained SDS-gel of urea-
extracted mesangial proteins (lane 1), bovine vimentin,
57 kD (lane 2), and chicken desmin, 53 kD (lane 3).
Western blots (lanes 4-6) ofthe same samples with cross-
reactive antiserum raised against SMI(I-19) (23-26)C
showed reactivity with three mesangial proteins (lane
4) and with vimentin (lane 5), but not with desmin (lane
6). The positions of the molecular weight standards are
indicated by arrows .
the mesangial extract was completely blocked by absorption of antiserum 8652 with
whole M1 but not M24 streptococci (data not shown), indicating the accessibility
of the crossreactive epitope on intact Ml protein .
These results suggested that the 56-kD protein is vimentin and the lower molec-
ular weight proteins are degradation products of this protein . It should be men-
tioned that the purchased vimentin was purified from bovine lens and the desmin
was purified from chicken stomach, whereas the proteins in the present study were
extracted from ratmesangial cells . The fact that the proteins originate from different
species and that the extracted proteins were applied to the gel in 4M urea, whereas
the purified proteins were applied in 0.3M urea, may account for the slight differ-
ence in the apparent molecular weights of bovine vimentin and the 56-kD protein .
To determine whethervimentin could inhibit the renal glomerular crossreactivity
of antiserum 8652, immunofluorescence inhibition tests were performed . Bovine
vimentin and the synthetic peptide SMl(1-26)C completely inhibited renal glomer-
ular fluorescence, whereas chickendesmin hadno inhibitory effect (Table I) . Moreover,
the crossreactive antibodies were completely absorbed by MI but not M24 strep-
tococcal cells (Table I) . These results indicated that the crossreactive antibodies bind
to the nativeM protein molecule and to similar determinants of authentic vimentin486
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" Bovine vimentin and chicken desmin were tested at a concentration of 0.5
mg/ml, and SM1(1-26)C was tested at a concentration of 100 AM.
$ To determine the exposure of the Ile-Arg-Leu-Arg epitope on the intact M
protein molecule, antiserum 8652 was absorbed twice at ambient temperature
for 30 min with pellets collected from 50 ml of an 18-h culture of M type I
and M type 24 streptococci.
and the glomerular crossreactive protein(s), providing additional evidence that the
crossreactive antigen is vimentin.
To further confirm this notion, we investigated whether monoclonal and polyclonal
antibodies against human vimentin would react with the crossreactive proteins ex-
tracted from mesangial cells. Both types of antibodies reacted strongly in Western
blots with the three crossreactive proteins extracted from rat mesangial cells (Fig.
3, lanes 2 and 3), whereas an mAb against human desmin did not react with any
ofthe extracted proteins (Fig. 3, lane 4). The mAbs against vimentin reacted with
renal glomeruli and mesangial cells in apattern identical to that ofthecrossreactive
antisera raised against the type 1 M protein peptide (not shown). The reactivity
ofthe mAbs against vimentin with all three crossreactive proteins indicate that the
56-kD protein most likely is vimentin and the two smaller proteins are degradation
products of this protein.
Localization of the Crossreactiae Epitope(s) of Vimentin.
￿
Since the glomerular cross-
reactive epitope of type 1 M protein previously was shown to be specified by the
tetrapeptide sequence Ile-Arg-Leu-Arg(12), we searched forhomologous amino acid
sequences in human vimentin (21). We found that vimentin contains the sequence
Arg-Leu-Arg, both at position 68-70 and at 183-185. To determine whether these
sequences flanked by adjacent sequences of Vimentin might be recognized by the
crossreactive antibodies, we synthesized two 11-residue peptides encompassing the
two Arg-Leu-Arg sequences and tested their crossreactivity in immunofluorescence
and Westernblot inhibition assays. The synthetic peptides, designated SV(63-73)C
and SV(178-188)C, both totally inhibited the glomerular crossreactivity ofantiserum
8652 (Table II). As previously reported (12), and as shown again in Table II for
comparison, peptides of MI protein containing the sequence Ile-Arg-Leu-Arg, but
not those lacking this sequence, similarly blocked immunofluorescence.
These results were confirmed in Western blot and quantitative ELISA inhibition
tests. Both syntheticpeptides ofvimentin encompassing the sequence Arg-Leu-Arg
blocked the reaction ofantiserum 8652 in Western blots with the urea-extracted pro-
teins ofmesangialcells as well as with authentic bovine vimentin (data not shown).





Western blot analysis of the reactivityofurea-extracted
mesangial proteins with antisera to vimentin and desmin . (Lane
1) Coomassie blue-stained SDS-gel of urea-extracted mesangial
proteins . Western blots (lanes 2-4) ofthe same sample showed reac-
tion of 56-, 52-, and 49-kD proteins with an mAb to human
vimentin (lane 2), with polyclonal antibodies to human vimentin
(lane 3), but not with anmAb to human desmin (lane 4) . All sera
were tested at a 1 :200 dilution .
32)C, both vimentin peptides were inhibitory in a dose-related fashion (Fig. 4) . On
a molar basis, however, the vimentin peptide SV(63-73)C was -100-fold more in-
hibitory then SV(178-188)C and was equal in potency to theM protein pentapep-
tide Ile-Arg-Leu-Arg-Cys . We chose peptide SMl(19-32)C as the ELISA antigen
TABLE II
Inhibition of Glomerular Crossreactioe Antibodies by
Synthetic Peptides of Human Vimentin
Each synthetic peptide was tested at a concentration of 100 uM, except for
IRLR_C, which was tested at a concentration of 5 mM .
The sequence of the NH2-terminal region oftype 1 M protein was confirmed
in a previous study (13) . The human vimentin sequence was derived from a
cDNA clone (21) . The single letter code for amino acid residues is used to con-
serve space and for ease of comparison .
Underscored cysteine residues were added for the purpose of coupling to a
carrier .
These data have been reported previously (12) and are shown again here for
comparison .
Inhibitory
peptide' Amino acid sequence:
Renal glomerular
fluorescence
None + + +
SV(63-73)C R S S A V R L R S S V _C4 -
SV(178-188)C AEDIMRLREKL_C -
SM1(19-32)CII A I QN I R L RH E NKD L _C -
SM1(23-26)CII I R L R C -
SM1(1-12)CII NGDGNPREV I EDC +++488
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FIGURE 4 .
￿
Inhibition of ELISA reactions of an-
tiserum 8652 with immobilized SMl(19-32)C by syn-
thetic peptides . A constant dilution (1:200) of anti-
SMl(1-19) (23-26)C was incubated with increasing
concentrations of SMI(19-32)C (A), SV(63-73)C
(Q), SV(178-188)C (A), SMI(23-26)C (M), and
SMl(1-12)C (x) as soluble inhibitors. The highest
concentration ofsynthetic peptides was 500AM and
the lowest concentration was 0.0064 AM, reached by
serial fivefold dilutions .
because it contains the epitope specified by Ile-Arg-Leu-Arg at positions 23-26 but
does not contain N112-terminal epitopes that would interfere with the ELISA reac-
tions of antiserum 8652 . Taken together, these results suggest that either or both
of the regions of the vimentin molecule containing the Arg-Leu-Arg sequence act
as the binding site(s) for theM protein crossreactive antibodies .
Discussion
In this study, we have shown that an antiserum raised against an NH2-terminal
peptide oftype 1M protein crossreacts with vimentin, acomponent ofthecytoskeleton
of eukaryotic cells . The cytoskeleton of most eukaryotic cells is composed of three
major fibersystems: themicrofilaments (5-6nm in diameter), themicrotubules (20-25
nm in diameter), and the intermediate filaments (7-11 nm in diameter) . Five major
classes of intermediate filaments have been described, reviewed by Lazarides (26,
27): the cytokeratins in epithelial cells, the neurofilaments in neurons, the filial fila-
ments in astrocytes, desmin in myogenic cells, andvimentin in various nonepithelial
cells, in particular, mesenchymal cells . The subunits ofeach ofthe intermediate fila-
ment proteins have common structural features, reviewed by Steinert and Parry(28) .
The subunit is composed ofa central a helix-rich (rod) domain of -311-314 amino
acid residues, and N112-terminal (head) and COOH-terminal (tail) domains of vari-
able sizeand chemical character. Generally, neither of the latter assume an a-helical
conformation . The a-helical domainsof these proteins give rise to acoiled-coil fibril
with the amino acid sequences following a seven-residue periodicity of the form
a-b-c-d-e-f-g, in which residues at positions a and d are usually apolar and those at
g are usually polar. This repeating pattern of residues gives rise to a coiled-coil fibril
with the apolar residues buried along its axis .
Each of theM proteins of group A streptococci studied thus far shows a similar
seven-residue periodicity of polar and apolar amino acids (13, 29, 30) . In addition,
it has been shown that theM proteins protrude as a-helical coiled-coil fibrils from
the surface of virulent strains of streptococci (9) . These fibrils render the organisms
resistant to recognition and ingestion by phagocytes of the nonimmune host (8, 10) .
The similarity oftheM protein a-helical structure to that ofmammalian coiled-coil
proteins, such as myosin, keratin, vimentin, desmin, and fibrinogen, was pointedKRAUS ET AL.
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out earlier by Manjula et al. (30). It should not be surprising, therefore, that the
only Mprotein crossreactive tissue proteins identified thus farbelong to this group
of proteins.
Krisher and Cunningham (5) first described a crossreaction of mAbs to type 5
streptococci with cardiacmyosin. Later it was shown that types 5, 6, and 19 Mpro-
teins contain epitopes that are shared with cardiac myosin (3, 4). Most recently, we
identified a renal glomerular crossreactive tetrapeptide sequence, Ile-Arg-Leu-Arg,
in the NH2 terminus oftype 1 M protein (12). Because the staining pattern ofthe
crossreactive antibodies suggested amesangial cell distribution ofthe antigen in the
glomeruli, we undertook the present study ofthe crossreactivity ofthese antibodies
with cultured mesangial cells.
The staining pattern obtained with mesangial cells and fibroblasts suggested that
intermediate filamentswere involved inthe crossreactions. Since onlytwo intermediate
filaments, desmin and vimentin, had been found in glomerular mesangial cells and
fibroblasts (25, 26, 31), we focusedourinvestigations onthese twoproteins and found
vimentin to be the autoimmune target. The evidence that vimentin is the target
is as follows: (a) the Mproteinpeptidecrossreactive antibodies reacted with authentic
vimentin but not desmin in Western blots; (b) vimentin, but not desmin, inhibited
the crossreactions both in immunofluorescence and Western blot tests; (c) mono-
clonal and polyclonal antibodies raised against human vimentin reacted with the
putative vimentin extracted from rat mesangial cells in the same pattern as that ob-
tained withthe crossreactive antiserum; (d)the mAbs against humanvimentin reacted
with glomeruli and mesangial cells in a pattern identical to that ofthe crossreactive
antibodies; and(e) synthetic peptides copying vimentin sequences encompassing the
tripeptide Arg-Leu-Arg inhibited the reaction ofthe Ml protein peptide antiserum
with mesangial cells and extracted vimentin.
Extensive homologies between the sequences ofvimentins ofdifferent specieshave
been reported . The sequence of human vimentin (21) is 98% homologous to that
ofSyrian hamstervimentin (32), and the hamstersequence exhibits 80% homology
with that ofchicken vimentin (33). The high degree ofhomology between the two
mammalian vimentin sequences suggests that the sequence ofrat vimentin is simi-
larly homologous. It is probable that the 56-kD protein, which is similar in molec-
ular mass to that ofhuman vimentin, represents rat vimentin and the lower molec-
ular weight proteins stained with the monoclonal antivimentin antibody represent
degradation products ofthis protein. Such degradation of vimentin had been no-
ticed in earlier studies by Franke et al. (34).
Because the crossreactive epitope of type 1 M protein was previously shown to
be specified by the tetrapeptide sequence Ile-Arg-Leu-Arg (12), we searched for ho-
mologies in the amino acid sequence of human vimentin (21). Two regions were
found containingthetripeptide sequence Arg-Leu-Argatpositions 68-70and 183-185.
Region 67-70 is part ofthe random-coil NH2-terminal (head) domain, whereas re-
gion 182-185 lies in the a-helical (rod) domain ofthe vimentin sequence. By com-
parison, the crossreactive epitope Ile-Arg-Leu-Arg at positions 23-26 oftype 1 M
protein is predicted to be located at the beginning ofthe a-helical coiled-coil struc-
ture ofthe molecule. Taking into account the primary and secondary structural fea-
tures ofthe potentially crossreactive epitopes in human vimentin and type 1 Mpro-
tein, one might predict that the sequence Arg-Leu-Arg at positions 183-185 in the490
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a-helical part of vimentin would be the major binding site of the crossreactive anti-
bodies . However, the two 11-residue synthetic peptides of vimentin encompassing
each of the Arg-Leu-Arg sequences and adjacent amino acids exhibited markedly
different potencies in their inhibitory activities against the crossreactive antiserum
8652 ; the peptide SV(63-73)C was -100-fold more inhibitory than SV(178-188)C .
We cannot conclude from these results which of these sites is more accessible in the
intact vimentin molecule because tertiary structural constraints undoubtedly play
a role (35) .
In this regard, the crossreactive antibodies did not react with chicken desmin, al-
though this protein contains an amino acid sequence, Arg-Leu-Arg, at positions
132-135 (36) . Either this sequence is inaccessible in the intact molecule or it does
not by itself represent an epitope that is recognized by antiserum 8652 ; sequence
identity of short peptides does not ensure similarity of structural shape (35) .
In summary, we have demonstrated that antibodies directed against the epitope
Ile-Arg-Leu-Arg of the nephritogenic type 1 M protein react with the intermediate
filament protein vimentin of renal glomerular mesangial cells . The identification
of the crossreactive antigen is one important step toward establishing a connection
between autoimmune reactions and the pathogenesis of acute poststreptococcal
nephritis . Further studies are in progress to assess the accessibility of mesangial cell
vimentin to the crossreactive antibodies and to determine the role of autoimmune
reactions to streptococcalM proteins in the generation of acute and chronic inflam-
matory diseases .
Summary
The crossreactivity ofantibodies against a renal autoimmune epitope ofStreptococcus
pyogenesM protein with glomerular mesangial cells was investigated . The antibodies
directed against theamino acid sequence Ile-Arg-Leu-Arg ofthe nephritogenic type
1 M protein reacted in a fibrillar pattern with mesangial cells cultured from isolated
glomeruli . In Western blots ofurea-extracted mesangial proteins, the antibodies reacted
with a 56-kD protein . Monoclonal and polyclonal antibodies identified the 56-kD
mesangial protein as vimentin . Two synthetic peptides ofhuman vimentin containing
the sequence Arg-Leu-Arg reacted with the autoimmune antibodies raised against
a streptococcal M protein peptide. These results provide evidence that the inter-
mediate filament protein vimentin shares autoimmune epitopes with streptococcal
M protein .
We thank Dr. Jerome Seyer for assistance in the synthesis and purification of peptides and
Pearly Howard for excellent secretarial assistance .
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